FIA
PRAH

FNY Investment Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

FNY Investment Advisers’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,100
Closed -$122K – 945
2019
Q4 		$122K Buy
+1,100
New +$113K 0.04% 328

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

FNY Investment Advisers's PRAH Position: Q1 2020 in Review

FNY Investment Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 1,100 shares — an estimated $122K sold.

FNY Investment Advisers first reported a position in PRAH in Q4 2019 and held it in 1 quarter. The position peaked at $122K in Q4 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • FNY Investment Advisers reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 1,100 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $122K.
  • FNY Investment Advisers first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 1 quarter.
  • FNY Investment Advisers's PRA Health Sciences, Inc. position peaked at $122K in Q4 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.